Takeda Pharmaceutical (TAK) Financial Analysis & Valuation | Quarter Chart

Takeda Pharmaceutical (TAK)

TAK
Price: $13.66
Fair Value: 🔒
🔒score
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of ga... more
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, ... more
Description Shares
Market Cap$43.07BExchangeNYSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryJPCEOChristophe Weber
IPO Date2010-01-05CAGR0.07%
Employees49,281Websitewww.takeda.com
Div. Yield5.84%Payout Ratio2.26%
Buy Back Yield284.64%Total Yield290.48%
TAK chart loading...
Fundamentals Technicals
Enterprise Value$11120.49BP/E Ratio195.14
Forward P/E—PEG Ratio0.26
P/S Ratio1.19P/B Ratio0.77
P/CF Ratio5.29P/FCF Ratio6.52
EPS$0.07EPS Growth 1Y-9.4%
EPS Growth 3Y-32.45%EPS Growth 5Y11.37%
Revenue Growth 1Y1.52%Gross Margin0.53%
Operating Margin0.13%Profit Margin0.03%
ROE0.02%ROA0.01%
ROCE0.05%Current Ratio1.16
Quick Ratio0.59Cash Ratio0.16
Debt/Equity0.66Interest Coverage2.21
Altman Z Score0.57Piotroski Score8

View Takeda Pharmaceutical financial charts →